The global medical bionic implant and artificial organs industry size is expected to reach US$ 70,818.8 million by 2033, forecast a CAGR of 8.8% and US$ 30,469.1 million in 2023. As the market for medical bionic implants and artificial organs expands, researchers and inventors are looking into new possibilities. Potential improvements include bioengineered organs for …
Category Archives: Healthcare Trends
Global Intranasal Corticosteroids Industry is expected to attain US$ 11.2 Billion by 2033, spurred by the quest for economical treatment options | FMI
The global intranasal corticosteroids industry size is predicted to expand at a CAGR of 5.0% during the forecasted period, according to data from Future Market Insights. From US$ 6.8 billion in 2023 to US$ 11.2 billion in 2033, the market value is anticipated to rise. The market for intranasal corticosteroids was estimated to be worth …
Global Radioimmunoassay Industry is anticipated to reach US$ 690.8 Million by 2033 with expand at a CAGR of 4.4%, as outlined by FMI
In 2023, the global radioimmunoassay industry size was valued at US$ 451.0 million, and by 2033, it is anticipated to reach US$ 690.8 million. Within the purpose category, the clinical use segment led the global market with a market share of more than 82.0%, and it is further projected to expand at a CAGR of …
Global Pain Therapeutic Injectables Industry might potentially achieve a US$ 30.9 billion valuation by 2033, according to FMI’s analysis of regional trends
The global pain therapeutic injectables Industry size is expected to develop at a CAGR of 4.5% between 2023 and 2033, with estimations for 2023 being about US$ 20.0 billion. By the end of 2033, the market is expected to reach US$ 30.9 billion. The Pain Therapeutic Injectables Market refer to medications that are administered through …
USA Medical Coding Industry is set to offer a lucrative investment avenue, with a projected value of US$ 2.3 Billion by 2033 | FMI
As per the analysis by Future Market Insights, the USA medical coding industry size is valued at US$ 1.0 Billion in 2023 and is projected to exhibit a CAGR growth of close to 8.4% over the forecast period, with an estimated valuation of US$ 2.3 Billion by 2033. Recent innovations in the field of medical …
Global 3D Printing Photopolymers Industry to achieve a value of US$ 5.0 Billion by 2033, with a CAGR of 18.3% | FMI
The global 3D printing photopolymers industry size is anticipated to reach US$ 935.0 million in 2023. Between 2023 and 2033, the market is forecast to increase at a CAGR of 18.3%, and by the end of 2033, it is anticipated to reach US$ 5.0 billion. 3D printing, also known as additive manufacturing, has emerged as …
Global USA Electronic Health Records (EHR) Industry is anticipated to soar to US$ 15.3 Billion by 2033 in the US Healthcare Sector, according to FMI’s analysis
The USA electronic health records (EHR) industry size is anticipated to reach a value of US$ 9.1 billion in 2023 and grow at a CAGR of 5.3% to reach US$ 15.3 billion by 2033. In 2022, the USA market will be led by EHR Software in the solution sector, with a market share of roughly …
Global VR Stroke Rehabilitation Industry is on an upward trajectory, anticipated to attain a value of US$ 376.0 billion by 2033, influenced by the increasing prevalence of strokes | FMI
The global VR stroke rehabilitation industry size is expected to reach US$ 376.0 billion by 2033, growing at a CAGR of 9.2% over the forecast period, according to a recent report by Future Market Insights. The growth of the VR stroke rehabilitation market is attributed to a number of factors, including the rising prevalence of …
Global Nephroblastoma Treatment Industry is projected to be US$ 5.44 Billion by 2033 | FMI
According to Future Market Insights, the global nephroblastoma therapeutics industry size is projected to rise at a steady growth valued at US$ 2.12 billion in 2023, with a 9.88% CAGR until 2033, being valued at US$ 5.44 billion. The important factors that are compelling the growth of the revenue of the nephroblastoma therapeutics market are …
Global Nerve Entrapment Syndrome Therapeutics Industry is expected to grow at a 6.81% CAGR and reach US$ 8.04 Billion by 2033 as per FMI’s study
According to Future Market Insights, the global nerve entrapment syndrome therapeutics industry size is projected to rise at a steady growth valued at US$ 4.16 billion in 2023, with a 6.81% CAGR until 2033, being valued at US$ 8.04 billion. As per FMI, around 60–70% of people suffering from diabetes are projected to have diabetic …